scholarly journals Rebalance of Striatal NMDA/AMPA Receptor Ratio Underlies the Reduced Emergence of Dyskinesia During D2-Like Dopamine Agonist Treatment in Experimental Parkinson's Disease

2012 ◽  
Vol 32 (49) ◽  
pp. 17921-17931 ◽  
Author(s):  
V. Bagetta ◽  
C. Sgobio ◽  
V. Pendolino ◽  
G. Del Papa ◽  
A. Tozzi ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist ◽  
Ampa Receptor

Impulse control disorders in Chinese Parkinson’s disease patients: The effect of ergot derived dopamine agonist

2011 ◽  
Vol 17 (8) ◽  
pp. 635-637 ◽  
Author(s):  
M. Auyeung ◽  
T.H. Tsoi ◽  
W.K. Tang ◽  
C.M. Cheung ◽  
C.N. Lee ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist ◽  
Impulse Control ◽  
Impulse Control Disorders

Antiparkinsonian activity of a non-ergot dopamine agonist, CV 205-502, in patients with fluctuating Parkinson's disease

1990 ◽  
Vol 5 (3) ◽  
pp. 257-259 ◽  
Author(s):  
W. Poewe ◽  
G. Luef ◽  
B. Kleedorfer ◽  
M. Emre
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist

Dual dopamine agonist treatment in Parkinson’s disease

2003 ◽  
Vol 250 (7) ◽  
pp. 822-826 ◽  
Author(s):  
Fabrizio Stocchi ◽  
Laura Vacca ◽  
Alfredo Berardelli ◽  
Marco Onofrj ◽  
Mario Manfredi ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist

Cabergoline: A long-acting dopamine agonist in Parkinson's disease

1990 ◽  
Vol 28 (4) ◽  
pp. 593-594 ◽  
Author(s):  
G. Lera ◽  
J. Vaamonde ◽  
J. Muruzabal ◽  
J. A. Obeso
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist ◽  
Long Acting
Sign in / Sign up

Export Citation Format

Share Document